Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - MERIDIAN BIOSCIENCE INC | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - MERIDIAN BIOSCIENCE INC | c16595exv31w1.htm |
| EX-31.2 - EXHIBIT 31.2 - MERIDIAN BIOSCIENCE INC | c16595exv31w2.htm |
| EX-10.22 - EXHIBIT 10.22 - MERIDIAN BIOSCIENCE INC | c16595exv10w22.htm |
| 10-Q - FORM 10-Q - MERIDIAN BIOSCIENCE INC | c16595e10vq.htm |
Meridian Bioscience, Inc.
Exhibit 32
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing with the Securities and Exchange Commission of the Quarterly Report
of Meridian Bioscience, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011 (the
“Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their
knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company. |
/s/ John A. Kraeutler |
||
Chief Executive Officer |
||
May 10, 2011 |
||
/s/ Melissa A. Lueke |
||
Executive Vice President and |
||
Chief Financial Officer |
||
May 10, 2011 |